Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1.
Hardik ChandasanaRajendra SinghKimberly AdkisonMounir Ait-KhaledTeodora Pene DumitrescuPublished in: Antimicrobial agents and chemotherapy (2024)
This study is registered with ClinicalTrials.gov as NCT03446573.